# Challenge IM

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/challenge-im

- Industry: Industrial Machinery
- Headquarters: Beijing, China
- Website: www.challengeim.com
- Latest round: Angel (Oct 10, 2024)
- Investors on record: 3

## About

Founded in 2022 and based in Beijing, China, Challenge IM operates as a manufacturing company that focuses on the development of membrane filtration process products. It was recognized as the National High-tech Enterprise. The company acquired ISO9001 quality system certification. It cooperated with GenScript, WuXi Biologics, BeiGene, and other enterprises. In October 2024, Challenge IM closed an angel funding.

The company's main business is the development and application of membrane filtration process products. Products include intelligent pumps, automatic tangential filtration systems, high-pressure homogenizers, etc. The products are widely used in multiple process links of multiple drug varieties such as antibodies and antibody-drug conjugates, cell gene therapy, vaccines, and nucleic acid drugs.

The company generates revenue by providing membrane filtration process products.

## Funding rounds

- Angel, Oct 10, 2024 — Genscript Biotech Corporation, Tao Capital, Tsinghua Innovation Ventures

## Investors

- Genscript Biotech Corporation — Angel
- Tao Capital (https://capitalatlas.ai/funds/tao-capital) — Angel
- Tsinghua Innovation Ventures (https://capitalatlas.ai/funds/tsinghua-innovation-ventures) — Angel